İdiyopatik Fibröz Mediastinite Sekonder Pulmoner Hipertansiyonlu Bir Adolesan: Olgu Sunumu

Onan, Sertaç Hanedan; Sezer, Sadettin; Baykan, Ali; Mavili, Ertuğrul; Gülmez, İnci; Canöz, Özlem; Narin, Nazmi
September 2012
Erciyes Medical Journal / Erciyes Tip Dergisi;2012, Vol. 34 Issue 3, p155
Academic Journal
Pulmonary hypertension is an important determinant of morbidity and mortality in many diseases, including congenital heart disease and respiratory disease. Fibrosing mediastinitis is a rare disorder caused by proliferation of acellular collagen. In fibrosing mediastinitis, clinical presentation is determined by compression to the vital mediastinal organs. Fibrosing mediastinitis may rarely lead to pulmonary veno-occlusive disease. In this case report, a 16 year old boy with pulmonary arterial hypertension was presented. His right pulmonary artery was completely occluded secondary to idiopathic fibrosing mediastinitis. The patient died after mediastinal biopsy. Herein, we discussed pulmonary arterial hypertension secondary to idiopathic fibrosing mediastinitis in children.


Related Articles

  • Epoprostenol treatment in children with severe pulmonary hypertension. Lammers, Asfrid E.; Hislop, Alison A.; Flynn, Yvette.; Haworth, Sheila G. // Heart;Jun2007, Vol. 93 Issue 6, p739 

    Introduction: Severe, sustained pulmonary arterial hypertension leads to a progressive reduction in exercise capacity, right heart failure and death. Use of intravenous epoprostenol has improved survival in adults, but data are limited in children. Patients and methods: This study included all...

  • Double switch operation in a young infant. Ishibashi, Nobuyuki; Aoki, Mitsuru; Fujiwara, Tadashi // Cardiology in the Young;Dec2004, Vol. 14 Issue 6, p661 

    We performed a combined Senning and arterial switch operation on a 2-month-old patient with congenitally corrected transposition, Ebstein's malformation producing severe tricuspid regurgitation, ventricular septal defect, pulmonary hypertension, and congestive heart failure. The tricuspid...

  • Poediatric respiratory disease: bench to bedside.  // Thorax;Dec2006 Supplement 2, Vol. 61, pii15 

    The article presents abstracts of medical research related to paediatric respiratory disease. They include "Congenital Heart Disease and Other Heterotaxic Defects in a Large Cohort of Patients With Primary Ciliary Dyskinesia," "The Roles of Angoipoietin-1 and Tie-2 in Lung Adaption at Birth and...

  • Clinical practice. Healy, Fiona; Hanna, Brian D.; Zinman, Raezelle // European Journal of Pediatrics;Jan2010, Vol. 169 Issue 1, p1 

    Pathologies in both the respiratory and cardiovascular systems frequently coexist and impact on each other. This manuscript introduces an approach to the interpretation of this complex relationship. Pulmonary hypertension can be a significant consequence of many respiratory diseases. This in...

  • Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease. Smadja, David M.; Gaussem, Pascale; Mauge, Laetitia; Lacroix, Romaric; Gandrille, Sophie; Remones, Véronique; Peyrard, Séverine; Sabatier, Florence; Bonnet, Damien; Lévy, Marilyne // Pediatric Cardiology;Jul2010, Vol. 31 Issue 5, p657 

    The reversibility of pulmonary arterial hypertension (PAH) in children with congenital heart disease (CHD) is strongly associated with the degree of intimal proliferation, vessel narrowing, and number of circulating endothelial cells (CECs). Circulating endothelial cells may arise from either...

  • Management of pulmonary hypertension in Down syndrome. Hawkins, Amy; Langton-Hewer, Simon; Henderson, John; Tulloh, Robert Michael // European Journal of Pediatrics;Jul2011, Vol. 170 Issue 7, p915 

    Unlabelled: Children with Down syndrome (DS) are at greater risk of pulmonary arterial hypertension (PAH) than the general population, partly due to upper airway obstruction and congenital heart disease. We wished to review our management of PAH and suggest a protocol for the...

  • Pulmonary Interstitial Glycogenosis: An Unrecognized Etiology of Persistent Pulmonary Hypertension of the Newborn in Congenital Heart Disease? Radman, Monique; Goldhoff, Patricia; Jones, Kirk; Azakie, Anthony; Datar, Sanjeev; Adatia, Ian; Oishi, Peter; Fineman, Jeffrey // Pediatric Cardiology;Jun2013, Vol. 34 Issue 5, p1254 

    Background: Pulmonary interstitial glycogenosis (PIG) arises from a developmental disorder of the pulmonary mesenchyme and presents clinically with reversible neonatal respiratory distress and/or persistent pulmonary hypertension of the newborn (PPHN). Objective: We report two cases of PIG in...

  • Seventeen years of adult congenital heart surgery: a single centre experience. Putman, Léon M.; van Gameren, Menno; Meijboom, Folkert J.; de Jong, Peter L.; Roos-Hesselink, Jolien W.; Witsenburg, Maarten; Takkenberg, Johanna J.M.; Bogers, Ad J.J.C. // European Journal of Cardio-Thoracic Surgery;Jul2009, Vol. 36 Issue 1, p96 

    Abstract: Objective: With a growing number of children with congenital heart disease (CHD) reaching adulthood, an extensive experience with cardiac surgery in adults with CHD is accumulating. To increase insight in this patient category we report our 17-year single centre experience including...

  • Surgically induced unilateral pulmonary hypertension: time-related analysis of a new experimental model. Corno, Antonio F.; Tozzi, Piergiorgio; Genton, Claude Y.; von Segesser, Ludwig K. // European Journal of Cardio-Thoracic Surgery;Apr2003, Vol. 23 Issue 4, p513 

    Objective: Patients with irreversible pulmonary vascular obstructive disease caused by pulmonary hypertension due to congenital heart defects are considered either inoperable or only candidates to lung transplantation. This study evaluated an experimental model of surgically induced unilateral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics